Biopharma Dealmakers Health sciences
Allogene Therapeutics: redefining the future of CAR-T
Abstract
Biopharma Dealmakers, Published online: 01 December 2025; doi:10.1038/d43747-025-00108-z The biotech is aiming to develop a first-line consolidation treatment for large B-cell lymphoma that predicts and prevents relapse.